Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07140692 · ClinicalTrials.gov registry record · NA
Effectiveness AND Safety Assessment OF THE Vista Vitrectomy Probe
A NA study of Vitreous Floaters and Vitreous Opacities, sponsored by The Eye Centers of Racine and Kenosha.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT07140692: Completed NA study of Vitreous Floaters and Vitreous Opacities, sponsored by The Eye Centers of Racine and Kenosha.
NCT07140692 is a NA study of Vitreous Floaters and Vitreous Opacities that has completed, run by The Eye Centers of Racine and Kenosha. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07140692, a NA study of Vitreous Floaters and Vitreous Opacities, has completed, sponsored by The Eye Centers of Racine and Kenosha.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Vitreous opacities or floaters are a common ocular condition that can cause significant impairment in vision-related quality of life (QoL) in some patients. Vitrectomy involves the surgical removal of vitreous humour, the transparent jelly, from inside the eye that contains vitreous opacities and floaters. The present post-market clinical assessment study aims to assess the safety and effectiveness performance of the Vista 1-Step vitrectomy probe in adult pseudophakic patients with visually symptomatic opacities.
Primary Outcome
iTrace Dysfunctional Lens Index (DLI) score
Conditions Studied
Interventions
- DEVICE Vitrectomy
Study Locations (1)
Wisconsin
- The Eye Centers of Racine & Kenosha - Kenosha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-09-14 |
| Est. Completion | 2024-07-01 |
| Phase | NA |
What the finished NCT07140692 record still lists
NCT07140692 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Vitreous Floaters appearing as the primary indexed condition, and to 1 intervention - of which Vitrectomy is the first listed.
NCT07140692 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT07140692 about?
NCT07140692 is a clinical study titled "Effectiveness AND Safety Assessment OF THE Vista Vitrectomy Probe". Vitreous opacities or floaters are a common ocular condition that can cause significant impairment in vision-related quality of life (QoL) in some patients. Vitrectomy involves the surgical removal of vitreous humour, the transparent jelly, from inside the eye that contains vitreous opacities and fl...
What is the current status of trial NCT07140692?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2023-09-14. Estimated completion is 2024-07-01.
What conditions does trial NCT07140692 study?
This clinical trial studies the following conditions: Vitreous Floaters, Vitreous Opacities.
What interventions are being tested in trial NCT07140692?
The interventions under investigation include: Vitrectomy (DEVICE).
Who is sponsoring clinical trial NCT07140692?
This trial is sponsored by The Eye Centers of Racine and Kenosha, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07140692 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07140692's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI